{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T05:16:47Z","timestamp":1781932607314,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100014589","name":"Chief Scientist Office, Scottish Government Health and Social Care Directorate","doi-asserted-by":"publisher","award":["HIPS 20\/09"],"award-info":[{"award-number":["HIPS 20\/09"]}],"id":[{"id":"10.13039\/100014589","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pilot Feasibility Stud"],"DOI":"10.1186\/s40814-025-01743-0","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T11:54:36Z","timestamp":1765540476000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A feasibility study of a co-designed intervention to manage benzodiazepine dependence and high-risk use in those receiving opioid agonist treatment"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7568-1125","authenticated-orcid":false,"given":"Catriona","family":"Matheson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Kilonzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Galea-Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trina","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Schofield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"MacLennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"1743_CR1","unstructured":"National Records of Scotland. Drug-related deaths in Scotland in 2022. 2022. https:\/\/www.nrscotland.gov.uk\/files\/statistics\/drug-related-deaths\/22\/drug-related-deaths-22-report.pdf."},{"key":"1743_CR2","unstructured":"National Records of Scotland. Drug-related deaths in Scotland in 2021. 2022. https:\/\/www.nrscotland.gov.uk\/files\/statistics\/drug-related-deaths\/21\/drug-related-deaths-21-report.pdf."},{"key":"1743_CR3","doi-asserted-by":"crossref","unstructured":"Votaw VR, Geyer R, Rieselbach MM, Mchugh RK. The epidemiology of benzodiazepine misuse: A systematic review. 2019 [cited 2020 Jun 2]; Available from: www.elsevier.com\/locate\/drugalcdep.","DOI":"10.1016\/j.drugalcdep.2019.02.033"},{"key":"1743_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103512","volume":"100","author":"A McAuley","year":"2022","unstructured":"McAuley A, Matheson C, Robertson JR. From the clinic to the street: the changing role of benzodiazepines in the Scottish overdose epidemic. Int J Drug Policy. 2022;100:103512. https:\/\/doi.org\/10.1016\/j.drugpo.2021.103512.","journal-title":"Int J Drug Policy"},{"key":"1743_CR5","unstructured":"Departments of Health. Drug Misuse and Dependence: UK Guidance on Clinical Management. 2017. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/673978\/clinical_guidelines_2017.pdf."},{"key":"1743_CR6","unstructured":"Public Health England. Report of Prescribed Medicines. 2019. https:\/\/www.gov.uk\/government\/publications\/prescribed-medicines-review-report\/prescribed-medicines-review-summary#findings-from-the-rapid-evidence-assessment."},{"key":"1743_CR7","doi-asserted-by":"crossref","unstructured":"Baandrup L, Ebdrup BH, Rasmussen JO, Lindschou J, Gluud C, Glenth\u00f8j BY. Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users. Cochrane Database of Systematic Reviews. 2018. Available at: https:\/\/www.cochrane.org\/CD011481\/ADDICTN_medications-discontinuation-long-term-benzodiazepine-use.","DOI":"10.1002\/14651858.CD011481.pub2"},{"key":"1743_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.drugalcdep.2017.01.013","volume":"174","author":"T Abrahamsson","year":"2017","unstructured":"Abrahamsson T, Berge J, \u00d6jehagen A, H\u00e5kansson A. Benzodiazepine, z-drug and pregabalin prescriptions and mortality among patients in opioid maintenance treatment-a nation-wide register-based open cohort study. Drug Alcohol Depend. 2017;174:58\u201364.","journal-title":"Drug Alcohol Depend"},{"issue":"11","key":"1743_CR9","doi-asserted-by":"publisher","first-page":"e1002965","DOI":"10.1371\/journal.pmed.1002965","volume":"16","author":"J Macleod","year":"2019","unstructured":"Macleod J, Steer C, Tilling K, Cornish R, Marsden J, Millar T, et al. Prescription of benzodiazepines, z-drugs, and gabapentinoids and mortality risk in people receiving opioid agonist treatment: observational study based on the UK Clinical Practice Research Datalink and Office for National Statistics death records. PLoS Med. 2019;16(11):e1002965.","journal-title":"PLoS Med"},{"issue":"5","key":"1743_CR10","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1111\/add.14886","volume":"115","author":"TW Park","year":"2020","unstructured":"Park TW, Larochelle MR, Saitz R, Wang N, Bernson D, Walley AY. Associations between prescribed benzodiazepines, overdose death and buprenorphine discontinuation among people receiving buprenorphine. Addiction. 2020;115(5):924\u201332.","journal-title":"Addiction"},{"key":"1743_CR11","doi-asserted-by":"crossref","unstructured":"Sharma V, Simpson SH, Samanani S, Jess E, Eurich DT. Concurrent use of opioids and benzodiazepines\/Z-drugs in Alberta, Canada and the risk of hospitalisation and death: a case cross-over study. BMJ Open 2020;10(11). [cited December 2022] Available at: https:\/\/bmjopen.bmj.com\/content\/bmjopen\/10\/11\/e038692.full.pdf.","DOI":"10.1136\/bmjopen-2020-038692"},{"key":"1743_CR12","doi-asserted-by":"publisher","first-page":"e074668","DOI":"10.1136\/bmjopen-2023-074668","volume":"14","author":"C Best","year":"2024","unstructured":"Best C, Matheson C, Robertson R, Ritchie C, et al. Association between benzodiazepine co-prescription and mortality in people on opioid replacement therapy: a population-based cohort study. BMJ Open. 2024;14:e074668. https:\/\/doi.org\/10.1136\/bmjopen-2023-074668.","journal-title":"BMJ Open"},{"issue":"1","key":"1743_CR13","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1177\/0269881116675508","volume":"31","author":"A Bakker","year":"2017","unstructured":"Bakker A, Streel E. Benzodiazepine maintenance in opiate substitution treatment: good or bad? A retrospective primary care case-note review. J Psychopharmacol. 2017;31(1):62\u20136.","journal-title":"J Psychopharmacol"},{"key":"1743_CR14","doi-asserted-by":"publisher","first-page":"j1550","DOI":"10.1136\/bmj.j1550","volume":"357","author":"L Sordo","year":"2017","unstructured":"Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550.","journal-title":"BMJ"},{"key":"1743_CR15","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1186\/s12913-023-10201-7","volume":"23","author":"K Berry","year":"2023","unstructured":"Berry K, Matheson C, Schofield J, Dumbrell J, Parkes T, Hill D, et al. Development of an intervention to manage benzodiazepine dependence and high-risk use in the context of escalating drug related deaths in Scotland: an application of the MRC framework. BMC Health Serv Res. 2023;23:1205. https:\/\/doi.org\/10.1186\/s12913-023-10201-7.","journal-title":"BMC Health Serv Res"},{"issue":"12","key":"1743_CR16","doi-asserted-by":"publisher","first-page":"e2348557","DOI":"10.1001\/jamanetworkopen.2023.48557","volume":"6","author":"DT Maust","year":"2023","unstructured":"Maust DT, Petzold K, Strominger J, Kim MH, Bohnert ASB. Benzodiazepine discontinuation and mortality among patients receiving long-term benzodiazepine therapy. JAMA Netw Open. 2023;6(12):e2348557.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"1743_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/10550880802122620","volume":"27","author":"B Brands","year":"2008","unstructured":"Brands B, Blake J, Marsh DC, Sproule B, Jeyapalan R, Li S. The impact of benzodiazepine use on methadone maintenance treatment outcomes. J Addict Dis. 2008;27(3):37\u201348.","journal-title":"J Addict Dis"},{"key":"1743_CR18","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jclinepi.2021.06.029","volume":"138","author":"C Chan","year":"2021","unstructured":"Chan C, Taljaard M, Lancaster GA, Brehaut JC, Eldridge SM. Pilot and feasibility studies for pragmatic trials have unique considerations and areas of uncertainty. J Clin Epidemiol. 2021;138:102\u201314.","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"1743_CR19","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/fampra\/cmh621","volume":"21","author":"SW Mercer","year":"2004","unstructured":"Mercer SW, Maxwell M, Heaney D, Watt GC. The consultation and relational empathy (CARE) measure: development and preliminary validation and reliability of an empathy-based consultation process measure. Fam Pract. 2004;21(6):699\u2013705. https:\/\/doi.org\/10.1093\/fampra\/cmh621.","journal-title":"Fam Pract"},{"key":"1743_CR20","doi-asserted-by":"publisher","unstructured":"Jones, K. Weatherly H., Birch, S., Castelli, A., Chalkley, M., Dargan, A., Forder, J., Gao, M., Hinde, S., Markham, S. Ogunleye, D. Premji, S., Roland, D. Unit Costs of Health and Social Care 2022 Manual. 2022. https:\/\/doi.org\/10.22024\/UniKent\/01.02.100519. KAR id:100519.","DOI":"10.22024\/UniKent\/01.02.100519"},{"key":"1743_CR21","unstructured":"Department of Health and Social Care. NHS Reference Costs 2021\u201322. London: Department of Health and Social Care. 2016. www.gov.uk\/government\/publications\/nhs-reference-costs-2015-to-2016.. Accessed 3 Jun 2023."},{"key":"1743_CR22","unstructured":"NHS England. National Schedule of Unit Costs: Year 2020\u20132021. NHS Trusts and Foundation Trusts. London 2022: NHS England and NHS Improvement. 2022"},{"key":"1743_CR23","unstructured":"Public Health Scotland. Scottish drug tariff Part 7 https:\/\/www.isdscotland.org\/Health-Topics\/Prescribing-and-Medicines\/Scottish-Drug-Tariff\/Drugs-and-Preparations-with-Tariff-Prices.asp. Accessed 27 Jul 2023."},{"key":"1743_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"EuroQoL Group","year":"1990","unstructured":"EuroQoL Group. EuroQoL: a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199\u2013208. https:\/\/doi.org\/10.1016\/0168-8510(90)90421-9.","journal-title":"Health Policy"},{"key":"1743_CR25","unstructured":"SPSS IBM Corp. IBM SPSS Statistics for Windows, Version 28.0. Armonk, NY: IBM Corp. 2021."},{"issue":"1\u20132","key":"1743_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.drugalcdep.2012.03.011","volume":"125","author":"J Delgadillo","year":"2012","unstructured":"Delgadillo J, Payne S, Gilbody S, Godfrey C, Gore S, Jessop D, et al. Brief case finding tools for anxiety disorders: validation of GAD-7 and GAD-2 in addictions treatment. Drug Alcohol Depend. 2012;125(1\u20132):37\u201342. https:\/\/doi.org\/10.1016\/j.drugalcdep.2012.03.011. Epub 2012 Apr 4 PMID: 22480667.","journal-title":"Drug Alcohol Depend"},{"key":"1743_CR27","unstructured":"Joint Formulary Committee. British National Formulary London: BMJ Group and Pharmaceutical Press http:\/\/www.medicinescomplete.com. Accessed on Jun 2023."},{"issue":"9","key":"1743_CR28","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"6","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;6(9):606\u201313. https:\/\/doi.org\/10.1046\/j.1525-1497.2001.016009606.x.","journal-title":"J Gen Intern Med"},{"issue":"1\u20133","key":"1743_CR29","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jad.2011.06.017","volume":"134","author":"J Delgadillo","year":"2011","unstructured":"Delgadillo J, Payne S, Gilbody S, Godfrey C, Gore S, Jessop D, et al. How reliable is depression screening in alcohol and drug users? A validation of brief and ultra-brief questionnaires. J Affect Disord. 2011;134(1\u20133):266\u201371. https:\/\/doi.org\/10.1016\/j.jad.2011.06.017. Epub 2011 Jul 1 PMID: 21723619.","journal-title":"J Affect Disord"},{"key":"1743_CR30","doi-asserted-by":"publisher","unstructured":"Neale J, Vitoratou S, Finch E, Lennon P, Mitcheson L, Panebianco D, Rose D, Strang J, Wykes T, Marsden J. \u2018Development and validation of \u2018SURE\u2019: A patient reported outcome measure (PROM) for recovery from drug and alcohol dependence\u2019. Drug Alcohol Depend. 2016;165:159-167. https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.06.006","DOI":"10.1016\/j.drugalcdep.2016.06.006"}],"container-title":["Pilot and Feasibility Studies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40814-025-01743-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40814-025-01743-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40814-025-01743-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T21:05:20Z","timestamp":1768165520000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40814-025-01743-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1743"],"URL":"https:\/\/doi.org\/10.1186\/s40814-025-01743-0","relation":{},"ISSN":["2055-5784"],"issn-type":[{"value":"2055-5784","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"12 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was granted on 29\/10\/2021, by the North of Scotland Ethics Committee, ref: 21\/NS\/0135 (IRAS 304108). All methods were carried out in accordance with relevant guidance and regulations, including GDPR.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from all participants prior to the commencement of data collection. All participants consented for data to be included in publications.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}